Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial

BACKGROUND: The CRASH-3 trial hypothesised that timely tranexamic acid (TXA) treatment might reduce deaths from intracranial bleeding after traumatic brain injury (TBI). To explore the mechanism of action of TXA in TBI, we examined the timing of its effect on death. METHODS: The CRASH-3 trial random...

Descripción completa

Detalles Bibliográficos
Autores principales: Brenner, Amy, Belli, Antonio, Chaudhri, Rizwana, Coats, Timothy, Frimley, Lauren, Jamaluddin, Sabariah Faizah, Jooma, Rashid, Mansukhani, Raoul, Sandercock, Peter, Shakur-Still, Haleema, Shokunbi, Temitayo, Roberts, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657351/
https://www.ncbi.nlm.nih.gov/pubmed/33172504
http://dx.doi.org/10.1186/s13054-020-03243-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657351/
https://www.ncbi.nlm.nih.gov/pubmed/33172504
http://dx.doi.org/10.1186/s13054-020-03243-4

Ejemplares similares